GEFs and Cancer
GEFs are potential target for cancer therapy due to their role in many signaling pathways, particularly cell proliferation. For example, many cancers are caused by mutations in the MAPK/ERK pathway that lead to uncontrolled growth. The GEF SOS1 activates Ras, whose target is the kinase Raf. Raf is a proto-oncogene because mutations in this protein have been found in many cancers. The Rho GTPase Vav1, which can be activated by the EGF receptor, has been shown to promote tumor proliferation in pancreatic cancer. GEFs represent possible therapeutic targets as they can potentially play a role in regulating these pathways through their activation of GTPases.
Read more about this topic: Guanine Nucleotide Exchange Factor
Famous quotes containing the word cancer:
“Madness is locked beneath. It goes into tissues, is swallowed by the cells. The cells go mad. Cancer is their flag. Cancer is the growth of madness denied.”
—Norman Mailer (b. 1923)